ALPN-101 clinical trials
Also written ALPN-101.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2019
How each study uses ALPN-101 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2019 (1)
| Year | Studies |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Alpine Immune Sciences, Inc. (2) · Alpine Immune Sciences Inc, A Subsidiary of Vertex (1)
Related medicines
As reviewed, each with the page that says it.
- One of Immunosuppressive Agents source
Studies
Open first, then newest update. How each study uses ALPN-101 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- ALPN-101 (Acazicolcept) in Systemic Lupus ErythematosusCompletedPhase 2Alpine Immune Sciences Inc, A Subsidiary of VertexNCT04835441Written as ALPN-101How we know
- ALPN-101 in Steroid-resistant or Steroid-refractory Acute GVHDTerminatedPhase 1Alpine Immune Sciences, Inc.NCT04227938Written as ALPN-101How we know
- Adult Healthy Volunteers Study to Evaluate ALPN-101 SafetyCompletedPhase 1Alpine Immune Sciences, Inc.NCT03748836Written as ALPN-101How we know
Codes
What other systems call ALPN-101 · ClinicalTrials.gg INT001904
- MeSH (NLM) C000722908ALPN-101One source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000722908 | ALPN-101 | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.